Gary Chan

56 papers receiving 2.4k citations

Gary Chan's Hit Papers

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis 2020 · 305 citations
3050+3+6Years since publication100200300

Peers

Gary Chan
Comparison fields: 5 of 85
  • Dermatology 574
  • Immunology and Allergy 236
  • Rheumatology 527
  • Genetics 819
  • Immunology 449
Replace B. Sassolas with:
B. Sassolas France
Joung-Liang Lan Taiwan
Huaming Tan United States
Luminita Pricop United States
Howard Sofen United States
Thomas Judge United States
Taeko Ishii Japan
Daniel Burge United States
J. Wollenhaupt Germany
Wojciech Niezychowski United States
Gary Chan relative to B. Sassolas France B. Sassolas's profile →
Citations per field
00.5×7.4×
B. Sassolas · 1×
Citations per year

Countries citing papers authored by Gary Chan

Since Specialization
Citations

This map shows the geographic impact of Gary Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Chan more than expected).

Fields of papers citing papers by Gary Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Chan. The network helps show where Gary Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary Chan Line = papers co-authored together Gary Chan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis
Hit paper breakdown →
2020305
2
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Hit paper breakdown →
2017300
3 2014217
4 2018197
5 2008173
6 2018169
7 2021114
8 201982
9 201965
10 200859
11 202259
12 201056
13 201649
14 200947
15 201545
16 201344
17 201341
18 201436
19 201934
20 202032

About Gary Chan

Gary Chan is a scholar working on Dermatology, Genetics, Immunology, Epidemiology and Surgery, having authored 59 papers that have together received 2.4k indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (19 papers), Inflammatory Bowel Disease (16 papers), Pharmacological Effects of Natural Compounds (7 papers), Microscopic Colitis (5 papers), Diagnosis and treatment of tuberculosis (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Cytokine Signaling Pathways and Interactions (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). The work is most often cited by research in Dermatology (574 citations), Immunology and Allergy (236 citations), Rheumatology (527 citations), Genetics (819 citations) and Immunology (449 citations). Gary Chan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nervin Lawendy, Chudy I. Nduaka, Chinyu Su, Sriram Krishnaswami, Bruce E. Sands, Hernán Valdez, Julián Panés, Michele Moscariello, Marco DiBonaventura and William J. Sandborn. Their work appears in journals such as Journal of Crohn s and Colitis, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Dermatology and Therapy and Journal of the European Academy of Dermatology and Venereology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact